Source: Aleafia Health Inc.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022
  • Branded cannabis net revenue increased 24 per cent to a record $10 million from $8 million quarter over quarter
  • The company’s net revenue increased 107 per cent to $6.7 million from $3.2 million in the same period last year
  • The company’s guidance is steady to deliver at least $53 million in total net revenue in fiscal year 2023, with a current run-rate of $48 million
  • Aleafia Health Inc. (AH) is up 7.69 per cent trading at C$0.07 per share as of 10:05 am ET.

Aleafia Health (AH) reported its financial results for the three months ended June 30, 2022.

Branded cannabis net revenue increased 24 per cent to a record $10 million from $8 million quarter over quarter. In the key branded adult-use market, the company’s net revenue increased 107 per cent to $6.7 million from $3.2 million in the same period last year.

Aleafia also highlighted a 12 per cent increase in medical cannabis net revenue over the prior quarter and a 7.5 per cent market share in overall Canadian medical market.

Tricia Symmes, Aleafia Health’s CEO explained that the company’s pivot to a branded cannabis strategy was supported by three pillars of revenue: adult-use branded cannabis, a ‘sticky’ recurring medical cannabis revenue stream and growing higher margin international sales.

“As a result of revenue increases, the company has achieved the 2nd highest growth rate amongst top 12 Canadian LPs in retail sell through over the prior quarter while achieving a #12 ranking for market share in our core markets for Q2 CY2022.”

The company’s CFO, Matt Sale added that its guidance is steady to deliver at least $53 million in total net revenue in fiscal year 2023, with a current run-rate of $48 million.

Aleafia Health owns three licensed cannabis production facilities and operates a strategically located distribution centre in the province of Ontario, including the first large-scale, legal outdoor cultivation facility in Canadian history.

Aleafia Health Inc. (AH) is up 7.69 per cent trading at C$0.07 per share as of 10:05 am ET.


More From The Market Herald
VitalHub

" VitalHub (TSX:VHI) announces multi year contract with NHS Mid and South Essex ICB

VitalHub (VHI) announced a multi-year licensing contract with NHS Mid and South Essex Integrated Care Board (Essex).
Resverlogix Corp. - SVP of Clinical Development, Dr. Michael Sweeney.

" Resverlogix (TSX:RVX) focuses drug development on COVID-19

Clinical development of Resverlogix’s (RVX) candidate apabetalone will remain focused on preventing and treating post-COVID-19 conditions.

" No pain, no blood: BETTER Type 2 diabetes testing is coming to market

Over the past two years, reporting on the Covid-19 pandemic has dominated media airwaves.
The Market Herald Video

" BioVaxys (CSE:BIOV) expands vaccines intellectual property portfolio

BioVaxys Technology Corp. (BIOV) has broadened patent coverage for its viral vaccine platform.